FDA tells oncology companies how to run multi-regional cancer trials with a US approval in mind

The FDA on Monday released new draft guidance on conducting multi-regional oncology trials, saying its “paramount consideration” is whether the results apply to the intended …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Oldest Patient ‘Cured’ of HIV Still in Remission 5 Years After Transplant for AML

A 68-year-old man with HIV-1 who underwent hematopoietic cell transplant (HCT) for acute myelogenous leukemia 5 years ago has been free of HIV infection for

February 15, 2024

Medical Experts Utilize NVIDIA-Powered Federated Learning to Advance AI in Tumor Segmentation

What You Should Know: – A team of experts from leading U.S. medical centers and research institutions is utilizing NVIDIA-powered federated learning to investigate the

September 23, 2024

Atezolizumab Consolidation Impresses in High-Risk DLBCL

Postchemotherapy consolidation with atezolizumab (Tecentriq) led to a surprisingly high 2-year disease-free survival (DFS) in high-risk diffuse large B-cell lymphoma (DLBCL), a prospective nonrandomized trial

June 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.